Third Party Funds Group - Sub project (01.04.2024 – 31.12.2027)
Part of TRR 369: DIONE Entzündungsbedingte Knochendegeneration (SFB TRR 369)
Third Party Funds Group - Sub project (01.04.2024 – 31.12.2027)
Part of TRR 369: DIONE Entzündungsbedingte Knochendegeneration (SFB TRR 369)
Third Party Funds Group - Sub project (01.04.2024 – 31.12.2027)
Part of TRR 369: DIONE Entzündungsbedingte Knochendegeneration (SFB TRR 369)
Third Party Funds Group - Sub project (01.04.2024 – 31.12.2027)
Part of TRR 369: DIONE Entzündungsbedingte Knochendegeneration (SFB TRR 369)
Third Party Funds Group - Sub project (01.04.2024 – 31.12.2027)
Part of TRR 369: DIONE Entzündungsbedingte Knochendegeneration (SFB TRR 369)
Third Party Funds Group - Sub project (01.04.2024 – 31.12.2027)
Part of TRR 369: DIONE Entzündungsbedingte Knochendegeneration (SFB TRR 369)
Third Party Funds Group - Sub project (01.01.2024 – 31.12.2027)
Part of Immun-Checkpoints der Kommunikation zwischen Darm und Gehirn bei entzündlichen und neurodegenerativen Erkrankungen (GB.com)
Third Party Funds Group - Sub project (01.01.2024 – 31.12.2027)
Part of Software Campus 3.0
Third Party Funds Group - Sub project (01.01.2023 – 31.12.2027)
Part of Testing and Experimentation Facility for Health AI and Robotics
Third Party Funds Group - Sub project (01.01.2023 – 31.12.2027)
Part of Personalized Drug Response: IMplementation and Evaluation in CKD